Two in Ten Thousand — What the JAMA Heart-Protection Study Proves and What It Doesn't
·1289 words·7 mins
A methodologically sound observational study — negative controls null, twelve consistent sensitivity runs — shows: those who take the 2024/25 booster suffer fewer major cardiac events over eight months, by 2 in 10,000, significant almost only for the over-75s. The political fight over it overreaches in both directions.